Study on the relationship between Vitamin D deficiency and Leukocyte Ratio in Multidrug Resistant Tuberculosis patients
DOI:
https://doi.org/10.35882/ijahst.v3i6.300Abstract
Tuberculosis (TB) remains an important health problem in Indonesia,the problems more complex with phenomenon of multi-drug resistance Tuberculosis (MDR) which cause worse prognosis, long treatment,high risk of transmission to other and side effect of treatment. Vitamin D plays a role in non specific and specific immune responses in Mycobacterium tuberculosis (M.tb) infection. Vitamin D have a role in hematopoiesis and affects the early development of monocytes and granulocytes. M.tb infection causes changer in the ratio of neutrophil cells, lymphocytes and monocytes. Changes in the ratio reflect an increase or decrease of effective immune response. Using a case control design, this study will evaluate the correlation between vitamin D, leukocyte ratio and MDR-TB patients among MDR-TB patient cases and TB patient controls. Independent variable in this study were vitamin D levels, leukocyte ratios consisting of NLR, MLR, NMLR, and clinical status of respondents were the dependent variable. The result of this study found that vitamin D levels of TB patients all showed values that were within range of in the insufficiency and deficiency categories. From this result TB patients must coverIn addition, the NLR and NMLR parameters were able to show that immune status problems were mainly found in the MDR-TB patients
Downloads
References
Kementrian Kesehatan Republik Indonesia, “Laporan_Nasional_RKD2018_FINAL.pdf,” Badan Penelitian dan Pengembangan Kesehatan. p. 674, 2018, [Online]. Available: http://labdata.litbang.kemkes.go.id/images/download/laporan/RKD/2018/Laporan_Nasional_RKD2018_FINAL.pdf.
WHO, Tuberculosis Report, vol. XLIX, no. 9-10–11. 2020.
D. K. provinsi Jambi, “PROFIL,” 2019.
Dinas Kesehatan Provinsi Jambi, “Profil Kesehatan Jambi,” Dk, vol. 53, no. 9, pp. 1689–1699, 2020.
Dinas Kesehatan Provinsi Jambi, “Profil Kesehatan Jambi,” Dk, vol. 53, no. 9, pp. 1689–1699, 2021.
P. Chandrasekaran, N. Saravanan, R. Bethunaickan, and S. Tripathy, “Malnutrition: Modulator of immune responses in tuberculosis,” Front. Immunol., vol. 8, no. OCT, pp. 1–8, 2017, doi: 10.3389/fimmu.2017.01316.
S.-J. Huang et al., “Vitamin D deficiency and the risk of tuberculosis a meta-analysis,” Dovepress, 2016, doi: 10.1016/j.clnesp.2021.12.005.
N. Herlina, B. Y. M. Sinaga, P. Siagian, and E. Mutiara, “Serum vitamin d level and susceptibility to multidrug-resistant tuberculosis among household contacts,” IOP Conf. Ser. Earth Environ. Sci., vol. 125, no. 1, pp. 0–6, 2018, doi: 10.1088/1755-1315/125/1/012143.
G. Brown, A. Kutner, and E. Marcinkowska, “Vitamin D and Haematopoiesis,” Curr. Tissue Microenviron. Reports, vol. 1, no. 1, pp. 1–11, 2020, doi: 10.1007/s43152-020-00001-0.
J. Pieters, “Mycobacterium tuberculosis and the Macrophage: Maintaining a Balance,” Cell Host Microbe, vol. 3, no. 6, pp. 399–407, 2008, doi: 10.1016/j.chom.2008.05.006.
R. Ocaña-Guzmán et al., “Leukocytes from Patients with Drug-Sensitive and Multidrug-Resistant Tuberculosis Exhibit Distinctive Profiles of Chemokine Receptor Expression and Migration Capacity,” J. Immunol. Res., vol. 2021, 2021, doi: 10.1155/2021/6654220.
D. Elisabeth Sormin, P. Siagian, B. Y. Sinaga, and P. Chairani Eyanoer, “Neutrophyl Lymphocyte Ratio pada Pasien Tuberkulosis Paru dan Tuberkulosis Resisten Obat Neutrophyl Lymphocyte Ratio in Tuberculosis Patients and Multi Drug Resistant Tuberculosis Patients,” Kata Kunci NLR, vol. 38, no. 3, pp. 177–80, 2018.
Melviana, B. Y. M. Sinaga, and N. A. Lubis, “Vitamin D Deficiency Prevalence and Its Association with Bacterial Load Sputum in Newly Diagnosed TB Patients Prevalensi Defisiensi Vitamin D pada Pasien TB Paru Baru dan Hubungan dengan Derajat Kepositifan Sputum Basil Tahan Asam,” Maj. Kedokt. Bandung, vol. 52, no. 53, pp. 1–5, 2020.
X. Liu, O. Sitsel, K. Wang, and P. Gourdon, “Chapter 5 Overproduction of P IB -Type ATPases,” P-Type ATPases Methods Protoc., vol. 1377, pp. 29–36, 2016, doi: 10.1007/978-1-4939-3179-8.
S. S. M. S. Elsafi, B. M. Nour, A. D. Abakar, I. H. Omer, and B. S. Almugadam, “Vitamin D level and it is association with the severity of pulmonary tuberculosis in patients attended to Kosti teaching hospital, Sudan,” AIMS Microbiol., vol. 6, no. 1, pp. 64–74, 2020, doi: 10.3934/microbiol.2020004.
N. Talat, S. Perry, J. Parsonnet, G. Dawood, and R. Hussain, “Vitamin D deficiency and tuberculosis progression,” Emerg. Infect. Dis., vol. 16, no. 5, pp. 853–855, 2010, doi: 10.3201/eid1605.091693.
V. Jaimni et al., “Association of Vitamin D Deficiency and Newly Diagnosed Pulmonary Tuberculosis,” Pulm. Med., vol. 2021, no. October 2014, 2021, doi: 10.1155/2021/5285841.
D. Ganmaa et al., “Vitamin D Supplements for Prevention of Tuberculosis Infection and Disease,” N. Engl. J. Med., vol. 383, no. 4, pp. 359–368, 2020, doi: 10.1056/nejmoa1915176.
K. Junaid and A. Rehman, “Impact of vitamin D on infectious disease-tuberculosis-a review,” Clin. Nutr. Exp., vol. 25, pp. 1–10, 2019, doi: 10.1016/j.yclnex.2019.02.003.
G. Abebe and W. K. , Zegeye Bonsa, “Treatment Outcomes and Associated Factors in Tuberculosis Patients at Jimma University Medical Center: A 5‑Year Retrospective Study Gemeda,” Int. J. Mycobacteriology, vol. 6, no. 3, pp. 239–245, 2017, doi: 10.4103/ijmy.ijmy.
D. E. Sormin, P. Siagian, B. Y. Sinaga, and P. C. Eyanoer, “Neutrophyl Lymphocyte Ratio in Tuberculosis Patients and Multi Drug Resistant Tuberculosis Patients,” J. Respirologi Indones., vol. 38, no. 3, pp. 177–180, 2018, doi: 10.36497/jri.v38i3.8.
B. Wicaksono, “Monocyte Lymphocyte Ratio, Platelet Lymphocyte Ratio, Neutrophil Lymphocyte Ratio as Prognostic Markers in Patients with Multidrugs Resistant Tuberculosis Treated at Ulin General Hospital Banjarmasin,” Berk. Kedokt., vol. 14, no. 2, p. 165, 2018, doi: 10.20527/jbk.v14i2.5330.
Y. La Jeon, W. I. Lee, S. Y. Kang, and M. H. Kim, “Neutrophil-to-Monocyte-Plus-Lymphocyte Ratio as a Potential Marker for Discriminating Pulmonary Tuberculosis from Nontuberculosis Infectious Lung Diseases,” Lab Med., vol. 50, no. 3, pp. 286–291, 2019, doi: 10.1093/labmed/lmy083.
M. Mabrouk, “Differential Count and Total White Blood Cells among Tuberculosis Patients under Treatment Attending Kenana Hospital in White Nile State,” J. Blood Disord., vol. 4, no. 1, pp. 4–7, 2017.
Y. Han et al., “High blood neutrophil-lymphocyte ratio associated with poor outcomes in miliary tuberculosis,” J. Thorac. Dis., vol. 10, no. 1, pp. 339–346, 2018, doi: 10.21037/jtd.2017.12.65.
H. Liu, Y. Li, J. Yi, W. Zhou, S. Zhao, and G. Yin, “Neutrophil–lymphocyte ratio as a potential marker for differential diagnosis between spinal tuberculosis and pyogenic spinal infection,” J. Orthop. Surg. Res., vol. 17, no. 1, pp. 1–5, 2022, doi: 10.1186/s13018-022-03250-x.
K. Kart, M. Kesavan, P. Tam, M. Saravanan, and M. Dashprakash, “N e u t r oph ils in t u be r cu losis : w ill code be u n lock e d ?,” pp. 118–121, 2013.
R. S. Martantya, E. Nasrul, and M. Basyar, “Gambaran Hitung Jenis Leukosit pada Pasien Penyakit Paru Obstruktif Kronik yang Dirawat di RSUP Dr. M. Djamil Padang,” J. Kesehat. Andalas, vol. 3, no. 2, pp. 217–220, 2014, doi: 10.25077/jka.v3i2.94.
J. Wang et al., “Ratio of monocytes to lymphocytes in peripheral blood in patients diagnosed with active tuberculosis,” Brazilian J. Infect. Dis., vol. 19, no. 2, pp. 125–131, 2015, doi: 10.1016/j.bjid.2014.10.008.
W. Wang, L. F. Wang, Y. Y. Liu, F. Yang, L. Zhu, and X. H. Zhang, “Value of the ratio of monocytes to lymphocytes for monitoring tuberculosis therapy,” Can. J. Infect. Dis. Med. Microbiol., vol. 2019, 2019, doi: 10.1155/2019/3270393.
R. K. Choudhary et al., “Monocyte-to-lymphocyte ratio is associated with tuberculosis disease and declines with Anti-TB Treatment in HIV-infected children,” J. Acquir. Immune Defic. Syndr., vol. 80, no. 2, pp. 174–181, 2019, doi: 10.1097/QAI.0000000000001893.
C. A. Rees et al., “The potential of CBC-derived ratios (monocyte-to-lymphocyte, neutrophil-to-lymphocyte, and platelet-to-lymphocyte) to predict or diagnose incident TB infection in Tanzanian adolescents,” BMC Infect. Dis., vol. 20, no. 1, pp. 1–10, 2020, doi: 10.1186/s12879-020-05331-w.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Fardiah tilawati Sitanggang
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlikel 4.0 International (CC BY-SA 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
